Faes Farma (Spain) Performance
| FAE Stock | EUR 3.56 0.04 1.14% |
The firm shows a Beta (market volatility) of -0.19, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Faes Farma are expected to decrease at a much lower rate. During the bear market, Faes Farma is likely to outperform the market. At this point, Faes Farma SA has a negative expected return of -0.0393%. Please make sure to confirm Faes Farma's standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if Faes Farma SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Faes Farma SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Faes Farma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 91.2 M | |
| Total Cashflows From Investing Activities | -83.5 M |
Faes |
Faes Farma Relative Risk vs. Return Landscape
If you would invest 366.00 in Faes Farma SA on August 31, 2024 and sell it today you would lose (10.00) from holding Faes Farma SA or give up 2.73% of portfolio value over 90 days. Faes Farma SA is producing return of less than zero assuming 0.8207% volatility of returns over the 90 days investment horizon. Simply put, 7% of all stocks have less volatile historical return distribution than Faes Farma, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Faes Farma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Faes Farma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Faes Farma SA, and traders can use it to determine the average amount a Faes Farma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0479
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FAE |
Estimated Market Risk
| 0.82 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Faes Farma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Faes Farma by adding Faes Farma to a well-diversified portfolio.
Faes Farma Fundamentals Growth
Faes Stock prices reflect investors' perceptions of the future prospects and financial health of Faes Farma, and Faes Farma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Faes Stock performance.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 1 B | |||
| Shares Outstanding | 306 M | |||
| Price To Earning | 20.64 X | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 2.33 X | |||
| Revenue | 398.56 M | |||
| EBITDA | 110.38 M | |||
| Cash And Equivalents | 56.13 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 3.5 M | |||
| Debt To Equity | 5.30 % | |||
| Book Value Per Share | 1.89 X | |||
| Cash Flow From Operations | 79.64 M | |||
| Earnings Per Share | 0.27 X | |||
| Total Asset | 641.76 M | |||
About Faes Farma Performance
By analyzing Faes Farma's fundamental ratios, stakeholders can gain valuable insights into Faes Farma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Faes Farma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Faes Farma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials. Faes Farma, S.A. was founded in 1933 and is headquartered in Madrid, Spain. FAES FARMA operates under Medical Instruments Supplies classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1264 people.Things to note about Faes Farma SA performance evaluation
Checking the ongoing alerts about Faes Farma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Faes Farma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Faes Farma SA generated a negative expected return over the last 90 days |
- Analyzing Faes Farma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Faes Farma's stock is overvalued or undervalued compared to its peers.
- Examining Faes Farma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Faes Farma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Faes Farma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Faes Farma's stock. These opinions can provide insight into Faes Farma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Faes Stock analysis
When running Faes Farma's price analysis, check to measure Faes Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faes Farma is operating at the current time. Most of Faes Farma's value examination focuses on studying past and present price action to predict the probability of Faes Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faes Farma's price. Additionally, you may evaluate how the addition of Faes Farma to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |